WO1994006747A1 - Resolution de cetoprofene - Google Patents
Resolution de cetoprofene Download PDFInfo
- Publication number
- WO1994006747A1 WO1994006747A1 PCT/US1992/007997 US9207997W WO9406747A1 WO 1994006747 A1 WO1994006747 A1 WO 1994006747A1 US 9207997 W US9207997 W US 9207997W WO 9406747 A1 WO9406747 A1 WO 9406747A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- salt
- ketoprofen
- propionic acid
- alcohol
- cinchonidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B57/00—Separation of optically-active compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
Definitions
- the invention relates to a process for resolution of mixtures of enantiomeric arylpropionic acids and for obtaining one of the enantiomeric forms of the acids, in which the mixture is converted with a chiral base in an inert solvent to a diastereoisomeric salt and the desired acid enantiomer is separated therefrom.
- Chromatographic separation has been carried out using a variety of substrates.
- the object of the present invention is to provide an efficient and practical process for the separation of a racemic mixture of ketoprofen [(j-_)- ⁇ :-(3-benzoyl- phenyl)propionic acid] into its individual enantiomeric forms, particularly the S( + ) form.
- ketoproten-cinchonidine salt forms from a solution of an aliphatic ester and alkyl alcohol.
- the diastereomeric forms of the salt are readily separated and further purified in a single recrystallization.
- the separated salt is easily hydrolyzed to afford the highly pure (S)-( + )-ketoprofen without the need for any further recrystallization.
- aliphatic ester means an ester of the formula RC(O)OR 1 , where R and R ⁇ are the same or different and are to C 12 linear or branched alkyl, for example, methyl, ethyl, propyl, isopropyl, butyl, pentyl, neopentyl, hexyl, nonyl, dodecyl and the like.
- R and R t are the same or different and are to C 6 linear or branched alkyl.
- Most preferred are the to C 6 linear or branched alkyl esters of acetic acid.
- a particularly preferred aliphatic ester is ethyl acetate.
- Alkyl alcohol means the C t to C 12 linear or branched alkyl alcohols such as methanol, ethanol, n-propanol, n-butanol, n-hexanol, 2-ethylhexanol, nonan-1-ol and the like.
- the alkyl group is a to C 6 linear or branched alkyl. Particularly preferred is methanol.
- racemic ketoprofen obtained commercially, is dissolved in a solvent mixture of an aliphatic ester and alkyl alcohol. The solution is heated to from 30 ° C to 70 ° C, preferably 50-60 ° C, and cinchonidine is added. Typically for best results, an equal equivalent weight of cinchonidine to ketoprofen is used in this reaction. However, it should be understood that more than an equivalent weight of cinchonidine can be used, facilitating the complete reaction of the ketoprofen.
- the solvent system ratios are critical to achieving the highly pure material isolated from the present process.
- the (volumetric) amount of aliphatic ester should be from 2 to 20 times the amount of alkyl alcohol, preferably 15 times, most preferably 7 to 12 times such amount.
- the ratio of salt to solvent is in the range of 1:0.2 to 1:100, preferably 1:0.6 to 1:15 (w/v).
- the diaster ⁇ eomeric salt is separated from the optionally cooled reaction solution.
- a single recrystallization (from ethyl acetate/methanol) produces a sufficiently pure salt for further (hydrolysis) treatment. While further recrystallizations are possible, they are not needed since the optical purity of the diasteromeric salt is very high, typically over 95%.
- the diastereomeric salt is cleaved with dilute hydrochloric and the S( + )ketoprofen separated.
- Cinchonidine (155 g; 0.53 mol) was added to a solution of 151 g (0.59 mol) of racemic ketoprofen and 2.8 L of ethyl acetate under vigorous stirring at 50-60 ° C. The mixture was diluted with 280 mL of methanol, cooled to 35 ° C, then seeded with 98% enantiomerically pure S-salt to induce crystallization.
- Parenthetical data are for samples prepared with purified MBA.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Procédé permettant de dissoudre de l'acide (±)-α-(-benzoylphényle)propionique qui consiste: i) à convertir ledit acide propionique à l'aide de (-)-cinchonidine en un solvant comprenant un mélange d'ester aliphatique et un alcool d'alkyle; ii) à séparer le sel diastéréomère du produit de conversion; iii) à purifier ledit sel diastéréomère séparé par une recristallisation unique; et (iv) à isoler l'acide (+)-α-(3-benzoylphényle)propionique sans aucune nouvelle recristallisation.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6508029A JPH07505165A (ja) | 1992-09-21 | 1992-09-21 | ケトプロフェンの分離 |
| PCT/US1992/007997 WO1994006747A1 (fr) | 1992-09-21 | 1992-09-21 | Resolution de cetoprofene |
| EP92920678A EP0613456A1 (fr) | 1992-09-21 | 1992-09-21 | Resolution de cetoprofene |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1992/007997 WO1994006747A1 (fr) | 1992-09-21 | 1992-09-21 | Resolution de cetoprofene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1994006747A1 true WO1994006747A1 (fr) | 1994-03-31 |
Family
ID=22231391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1992/007997 Ceased WO1994006747A1 (fr) | 1992-09-21 | 1992-09-21 | Resolution de cetoprofene |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0613456A1 (fr) |
| JP (1) | JPH07505165A (fr) |
| WO (1) | WO1994006747A1 (fr) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3705900A (en) * | 1970-03-09 | 1972-12-12 | Lilly Co Eli | Isomer resolution |
| EP0362476A2 (fr) * | 1988-07-19 | 1990-04-11 | Paz Arzneimittel- Entwicklungsgesellschaft Mbh | Procédé de dédoublement de mélanges d'acides arylpropioniques enatiomères |
| WO1992018455A1 (fr) * | 1991-04-15 | 1992-10-29 | Ethyl Corporation | Resolution de ketoprofene |
-
1992
- 1992-09-21 EP EP92920678A patent/EP0613456A1/fr not_active Withdrawn
- 1992-09-21 JP JP6508029A patent/JPH07505165A/ja active Pending
- 1992-09-21 WO PCT/US1992/007997 patent/WO1994006747A1/fr not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3705900A (en) * | 1970-03-09 | 1972-12-12 | Lilly Co Eli | Isomer resolution |
| EP0362476A2 (fr) * | 1988-07-19 | 1990-04-11 | Paz Arzneimittel- Entwicklungsgesellschaft Mbh | Procédé de dédoublement de mélanges d'acides arylpropioniques enatiomères |
| WO1992018455A1 (fr) * | 1991-04-15 | 1992-10-29 | Ethyl Corporation | Resolution de ketoprofene |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0613456A1 (fr) | 1994-09-07 |
| JPH07505165A (ja) | 1995-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5015764A (en) | Preparation of optically active aliphatic carboxylic acids | |
| US4983765A (en) | Process to separate mixtures of enantiomeric arylpropionic acids | |
| CA2150355C (fr) | Procede d'enrichissenment en un enantiomere donne d'acides phenylpriopioniques au moyen d'alpha-methylbenzylamine | |
| US5162576A (en) | Resolution of ketoprofen | |
| US5621140A (en) | Resolution of ibuprofen | |
| EP0298480B1 (fr) | Procédé pour le dédoublement optique d'acide (+)-cis ou (+)-trans-perméthrique | |
| JP2011526614A (ja) | ラセミ2−アリール−プロピオン酸の製造方法 | |
| Calmes et al. | Asymmetric synthesis of ketoprofen: A surprising base catalyst effect during asymmetric addition of pantolactone to methyl (3-benzoylphenyl) ketene | |
| WO1994006747A1 (fr) | Resolution de cetoprofene | |
| US5852209A (en) | Process for optically resolving 2-(3-benzoylphenyl) propionic acid | |
| JPH06184091A (ja) | 光学活性メチオニンアミドの調製法 | |
| EP0623107B1 (fr) | Preparation d'acides carboxyliques aliphatiques optiquement actifs | |
| JP5598330B2 (ja) | 光学活性有機カルボン酸の製造方法 | |
| US5574183A (en) | Preparation of optically active aliphatic carboxylic acids | |
| US4542235A (en) | Method for producing an optically active 2,2-dimethylcyclopropanecarboxylic acid | |
| EP0382506B1 (fr) | Sels diastéréoisomères optiquement actifs de l'acide tétrahydro-2-furoique | |
| RU2015953C1 (ru) | Способ расщепления рацемата 2,2-диметилциклопропанкарбоновой кислоты | |
| JP3784411B2 (ja) | 光学活性なカルボン酸のラセミ化法 | |
| FI96681C (fi) | Menetelmä 2,2-dimetyylisyklopropaanikarboksyylihapon rasemaattipilkkomiseksi | |
| Borde et al. | (R)-and (S)-α-Methoxy-(1-naphthyl) acetic acids: resolution by fractional crystallization and use for the NMR stereochemical analysis of alkylsulfoxides | |
| JPH11505525A (ja) | ジアステレオマーエステルの蒸留分離を含むラセミ体α−アリールプロピオン酸の光学的に純粋なα−アリールプロピオン酸への転化 | |
| JPH085840B2 (ja) | ジャスモン酸の光学分割方法 | |
| KR101198657B1 (ko) | (에스)-(+)-1-아미노인단을 이용한 광학활성을 갖는 2-아릴프로피온산 계열 약물들의 제조 방법 | |
| JPH05500966A (ja) | 再結晶によるアルコール―エステル分離 | |
| CA2044570A1 (fr) | Methode de resolution des racemates de l'acide 2,2-dimethyl cyclopropanedicarboxylique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1992920678 Country of ref document: EP |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWP | Wipo information: published in national office |
Ref document number: 1992920678 Country of ref document: EP |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1992920678 Country of ref document: EP |